MyMD Pharmaceuticals, Inc. (NASDAQ:MYMD – Get Free Report)’s stock price traded down 6.8% during mid-day trading on Friday . The company traded as low as $0.13 and last traded at $0.15. 6,687,900 shares changed hands during mid-day trading, an increase of 4,886% from the average session volume of 134,123 shares. The stock had previously closed at $0.16.
MyMD Pharmaceuticals Price Performance
The company has a 50-day moving average price of $0.20 and a two-hundred day moving average price of $0.62.
About MyMD Pharmaceuticals
MyMD Pharmaceuticals, Inc, a clinical development stage pharmaceutical company, focuses on developing various therapeutic platforms to treat the aging and age-related and autoimmune diseases, and chronic pain, anxiety, and sleep disorders. The company is developing MYMD-1, a drug platform based on a clinical stage small molecule that regulates the immune system and its pro-inflammatory cytokines to prevent and treat autoimmune diseases and age-related illnesses, and a Phase 2 clinical trial for sarcopenia, multiple sclerosis, diabetes, inflammatory bowel diseases, and rheumatoid arthritis; inflammation related depression and anxiety; and COVID-19-associated depression.
Featured Stories
- Five stocks we like better than MyMD Pharmaceuticals
- What is a SEC Filing?
- IBM Up 10 Days in a Row: What’s Driving the Winning Streak?
- What to Know About Investing in Penny Stocks
- Upstart Stock’s Bull Case Just Got a Lot Stronger
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- Higher Gulf Oil Output Puts These Energy Names in Play
Receive News & Ratings for MyMD Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MyMD Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
